New Imaging Techniques in Characterization of Adrenal Neoplasms
Amira Ayman Ahmed Shaheen;
Abstract
Most adrenal lesions are discovered during radiological
examinations performed for unrelated reasons. The clinically
silent adrenal masses incidentally detected are commonly referred
to as adrenal ‘‘incidentalomas’’ (Işık et al., 2012).
Adrenal gland can harpor a wide spectrum of pathology.
Most incidental adrenal masses are benign in patients without
malignancy, but in oncologic patients, adrenal glands are common
site of metastasis. Contemporary CT, MRI, and PET are excellent
imaging tools in the detection and characterization of adrenal
masses (Song & Mayo-Smith 2014).
Differentiating adenomas from metastases has been the major
objective in the radiological evaluation of adrenal masses, especially
in patients with a known primary malignancy (Işık et al., 2012).
Various imaging modalities have been investigated for their
ability to characterize adrenal lesions. In the context of lipid-rich
adenomas, Low-density (Hounsfield unit) values less than 10 HU
are characteristically observed on CT images. The metastatic
adrenal masses usually measure greater than 10 HU.
At CT washout analysis, metastatic masses usually show
delayed washout with APW less than 60% and RPW less than
Summary and conclusion
129
40%, while a value of APW greater than 60% and RPW greater
than 40% is diagnostic of adenoma (Song & Mayo-Smith 2014).
The CT histogram method with a threshold value of >10%
negative pixels can identify many benign adrenal nodules with
attenuation values >10 HU on unenhanced CT with extremely
high specificity (Bae et al., 2003).
Magnetic resonance imaging (MRI) using a chemical shift
technique, adenoma is diagnosed when an adrenal mass becomes
dark on out-of-phase compared with in-phase images, using the
spleen as the reference. Lack signal loss on opposed-phase is
observed in metastatic masses (Song & Mayo-Smith 2014).
However, drawing a clear distinction between metastases
and adenomas is not always possible, especially for lipid-poor
adenomas. Recent advances in image acquisition and post
processing techniques on both CT and MR are helping to expand
the research tools available for adrenal imaging (Holalkere&
Blake, 2009).
DWI has been shown to be helpful in characterization of
tumors on the basis of diffusion effects using apparent diffusion
coefficient (ADC) measurements, restriction of diffusion of water
molecules may provide strong evidence for malignancy in an
adrenal lesion. On the other hand, the lack of restricted diffusion
Summary and conclusion
130
may correlate with a benign or borderline neoplastic tumor.
however, there are limited studies on characterization of adrenal
lesions using DWI (Blake et al., 2009).
In vivo MRS is a noninvasive technique for evaluating the
various biochemical processes. MR spectroscopy may prove to be
useful in identifying fat in benign adrenal lesions. The presence of
a lipid peak at 1.3ppm on the MR spectra in an adrenal lesion
could confidently characterize adrenal lesions into a benign
category. Quantification of choline (Cho) containing compounds
at 3-3.3ppm is also of great interest because such compounds have
shown to be increased in malignancy. Thus, MRS is as a
promising tool in adrenal imaging with the continuing advances in
MR scanners and post processing techniques (Blake et al., 2010).
Numerous studies have evaluated the efficiency of positron
emission CT (PET-CT) in differentiating benign and malignant
adrenal lesions, in which lesions with low or no FDG activity are
mostly benign. Although this technique is reported to have high
sensitivity and specificity, it is well known that a subset of
adenomas demonstrates slightly increased uptake, and a subset of
metastatic lesions may not demonstrate any uptake (Blake et al.,
2010).
examinations performed for unrelated reasons. The clinically
silent adrenal masses incidentally detected are commonly referred
to as adrenal ‘‘incidentalomas’’ (Işık et al., 2012).
Adrenal gland can harpor a wide spectrum of pathology.
Most incidental adrenal masses are benign in patients without
malignancy, but in oncologic patients, adrenal glands are common
site of metastasis. Contemporary CT, MRI, and PET are excellent
imaging tools in the detection and characterization of adrenal
masses (Song & Mayo-Smith 2014).
Differentiating adenomas from metastases has been the major
objective in the radiological evaluation of adrenal masses, especially
in patients with a known primary malignancy (Işık et al., 2012).
Various imaging modalities have been investigated for their
ability to characterize adrenal lesions. In the context of lipid-rich
adenomas, Low-density (Hounsfield unit) values less than 10 HU
are characteristically observed on CT images. The metastatic
adrenal masses usually measure greater than 10 HU.
At CT washout analysis, metastatic masses usually show
delayed washout with APW less than 60% and RPW less than
Summary and conclusion
129
40%, while a value of APW greater than 60% and RPW greater
than 40% is diagnostic of adenoma (Song & Mayo-Smith 2014).
The CT histogram method with a threshold value of >10%
negative pixels can identify many benign adrenal nodules with
attenuation values >10 HU on unenhanced CT with extremely
high specificity (Bae et al., 2003).
Magnetic resonance imaging (MRI) using a chemical shift
technique, adenoma is diagnosed when an adrenal mass becomes
dark on out-of-phase compared with in-phase images, using the
spleen as the reference. Lack signal loss on opposed-phase is
observed in metastatic masses (Song & Mayo-Smith 2014).
However, drawing a clear distinction between metastases
and adenomas is not always possible, especially for lipid-poor
adenomas. Recent advances in image acquisition and post
processing techniques on both CT and MR are helping to expand
the research tools available for adrenal imaging (Holalkere&
Blake, 2009).
DWI has been shown to be helpful in characterization of
tumors on the basis of diffusion effects using apparent diffusion
coefficient (ADC) measurements, restriction of diffusion of water
molecules may provide strong evidence for malignancy in an
adrenal lesion. On the other hand, the lack of restricted diffusion
Summary and conclusion
130
may correlate with a benign or borderline neoplastic tumor.
however, there are limited studies on characterization of adrenal
lesions using DWI (Blake et al., 2009).
In vivo MRS is a noninvasive technique for evaluating the
various biochemical processes. MR spectroscopy may prove to be
useful in identifying fat in benign adrenal lesions. The presence of
a lipid peak at 1.3ppm on the MR spectra in an adrenal lesion
could confidently characterize adrenal lesions into a benign
category. Quantification of choline (Cho) containing compounds
at 3-3.3ppm is also of great interest because such compounds have
shown to be increased in malignancy. Thus, MRS is as a
promising tool in adrenal imaging with the continuing advances in
MR scanners and post processing techniques (Blake et al., 2010).
Numerous studies have evaluated the efficiency of positron
emission CT (PET-CT) in differentiating benign and malignant
adrenal lesions, in which lesions with low or no FDG activity are
mostly benign. Although this technique is reported to have high
sensitivity and specificity, it is well known that a subset of
adenomas demonstrates slightly increased uptake, and a subset of
metastatic lesions may not demonstrate any uptake (Blake et al.,
2010).
Other data
| Title | New Imaging Techniques in Characterization of Adrenal Neoplasms | Other Titles | التقنیات الحدیثة للتصویر الطبي المستخدمھ في توصیف أورام الغدة الكظریة | Authors | Amira Ayman Ahmed Shaheen | Issue Date | 2015 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.